Helicobacter pylori does not migrate from the antrum to the corpus in response to omeprazole

American Journal of Gastroenterology

Volumn 91, Issue 10, 1996, Pages 2120-2124

  Graham, David Y ^a,c   Genta, Robert ^a   Evans, Dolores G ^a   Reddy, Rita ^a   Clarridge, Jill E ^a   Olson, Carol A ^b   Edmonds, A L ^b   Siepman, Nancy ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ABBOTT LABORATORIES   (United States)

^c MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OMEPRAZOLE;

ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH FUNDUS;

ANTI-ULCER AGENTS; BIOPSY; COLONY COUNT, MICROBIAL; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OMEPRAZOLE; PYLORIC ANTRUM; STOMACH; TIME FACTORS;

EID: 0029821733     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Weil J, Bell GD, Powell K, et al. Omeprazole and Helicobacter pylori: Temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991;5:309-13.
2. Megraud F, Boyanova L, Lamouliatte H. Activity of lansoprazole against Helicobacter pylori. Lancet 1991;337:1486 (letter).
3. Iwahi T, Satoh H, Nakao M, et al. Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori. Antimicrob Agents Chemother 1991;35:490-6.
4. Bernersen B, Johnsen R, Straume B, et al. Erosive prepyloric changes in dyspeptics and non-dyspeptics in a defined population. The Srreisa Gastrointestinal Disorder Study. Scand J Gastroenterol 1992; 27:233-7.
5. Suerbaum S, Leying H, Klemm K, et al. Antibacterial activity of pantoprazole and omeprazole against Helicobacter pylori. Eur J Clin Microbiol Infect Dis 1991;10:92-3 (letter).
6. Sherman P, Shames B, Loo V, et al. Omeprazole therapy for Helicobacter pylori infection. Scand J Gastroenterol 1992;27:1018-22.
7. Vigneri S, Termini R, Scialabba A, et al. Omeprazole therapy modifies the gastric localization of Helicobacter pylori. Am J Gastroenterol 1991;86:1276 (letter).
8. Logan RP, Walker MM, Misiewicz JJ, et al. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995;36:12-6.
9. Goh KL, Tan KK, Anderson PE. Omeprazole may kill Helicobacter pylori. Am J Gastroenterol 1991;86:124 (letter).
10. Koop H, Stumpf M, Eissele R, et al. Antral Helicobacter pylori-like organisms in different states of gastric acid secretion. Digestion 1991; 48:230-6.
11. Archimandritis A, Tjivras M, Davaris P, et al. Effect of omeprazole on H. pylori after two weeks of treatment. Ital J Gastroenterol 1991;23: 357-8.
12. Mainguet P, Delmëe M, Debongnie JC. Omeprazole, Campylobacter pylori, and duodenal ulcer. Lancet 1989;2:389-90 (letter).
13. Catalano F, Mangiameli A, Inserra G, et al. Omeprazole vs. ranitidine in short-term treatment of Helicobacter pylori-positive duodenal ulcer patients. Ital J Gastroenterol 1991;23:9-11.
14. Daw MA, Deegan P, Leen E, et al. Short report: The effect of omeprazole on Helicobacter pylori and associated gastritis. Aliment Pharmacol Ther 1991;5:435-9.
15. Hui WM, Lam SK, Ho J, et al. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991;36:577-82.
16. Genta RM, Graham DY. Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: A topographic study of H. pylori density and distribution. Gastrointest Endosc 1994;40:342-5.
17. Stolte M, Eidt S, Ohnsmann A. Differences in Helicobacter pylori-associated gastritis in the antrum and body of the stomach. Z Gastroenterol 1990;28:229-33.
18. Bayerdörffer E, Lehn N, Hatz R, et al. Difference in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992;102:1575-82.
19. Bayerdörffer E, Oertel H, Lehn N, et al. Topographic association between active gastritis and Campylobacter pylori colonisation. J Clin Pathol 1989;42:834-9.
20. Stolte M, Bethke B. Elimination of Helicobacter pylori under treatment with omeprazole. Z Gastroenterol 1990;28:271-4.
21. Tsuchiya M, Suzuki M, Morishita T. Clinical efficacy of omeprazole for treatment of peptic ulcer: Bacterial clearance of Helicobacter pylori from gastric mucosa. Jpn Pharmacol Ther 1994;22:287-99.
22. Kuipers EJ, Klinkenberg-Knol EC, Festen HP, et al. Long-term omeprazole therapy does not affect Helicobacter pylori status in most patients. Scand J Gastroenterol 1993;28:978-80.
23. Kuipers EJ, Uyterlinde AM, Pena AS, et al. Increase of Helicobacter pylori-associated corpus gastritis during acid-suppressive therapy: Implications for long-term safety. Am J Gastroenterol 1995;90:1401-6.
24. Carlani G, Vandelli A, Santini D. Antral and body Helicobacter pylori status after short- and long-term omeprazole therapy. Eur J Gastroenterol Hepatol 1992;4:867-8.
25. Han SW, Flamm R, Hachem CY, et al. Transport and storage of Helicobacter pylori from gastric mucosal biopsies and clinical isolates. Eur J Clin Microbiol Infect Dis 1995;14:349-52.
26. Verdu EF, Frazer R, Armstrong D, et al. Lansoprazole and omeprazole at therapeutic doses produce equivalent rises in gastric pH in Helicobacter pylori-positive subjects. Gastroenterology 1995;106:A205 (abstract).
27. Rubinstein G, Dunkin K, Howard AJ. The susceptibility of Helicobacter pylori to 12 antimicrobial agents, omeprazole and bismuth salts. J Antimicrob Chemother 1994;34:409-13.
28. Vogt K, Hahn H. Influence of omeprazole on urease activity of Helicobacter pylori in vitro. Int J Med Microbiol Virol Parasitol Infect Dis 1993;280:273-8.
29. McGowan CC, Cover TL, Blaser MJ. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 1994;107:738-43.
30. Graham DY, Evans DJ Jr, Evans DG. Helicobacter pylori alcohol dehydrogenase in perspective: An interesting finding of doubtful clinical significance. Scand J Gastroenterol 1994;29:481-2.
31. Graham DY, Go MF, Evans DJ Jr. Urease, gastric ammonium/ ammonia, and Helicobacter pylori: The past, the present, and recommendations for future research. Aliment Pharmacol Ther 1992; 6:659-69.
32. Graham DY, Karttunen TJ, Genta RM. The evaluation of treatment of H. pylori infections: Strategies for the design of clinical trials. Endosc Dig 1994;6:991-1006.
33. El-Zimaity HMT, Al-Assi MT, Genta RM, et al. Confirmation of successful therapy of Helicobacter pylori infection: Number and site of biopsies or a rapid urease test. Am J Gastroenterol 1995; 90:1962-4.